Mexican petrochemical firm Braskem Idesa filed for Chapter 11 bankruptcy to restructure $3.6 billion in liabilities, aiming to reduce senior debt by $920 million amid a prolonged industry downturn and
Braskem SA released its Q1 2024 earnings report, missing consensus EPS expectations but beating revenue forecasts. The release includes details from the earnings call and slide deck alongside historic
Mexican petrochemical joint venture Braskem Idesa filed for Chapter 11 bankruptcy on August 17, 2026, citing constrained ethane supply and high feedstock costs. A restructuring agreement backed by sec
Braskem Idesa, a joint venture between Braskem and Grupo Idesa, filed for Chapter 11 bankruptcy to restructure debt at its Veracruz polyethylene plant. Braskem will inject $476 million to retain major
Braskem reported strong Q2 2026 EBITDA driven by higher international spreads and a supply shock across all segments. However, the company forecasts spread normalization and faces ongoing challenges f
Braskem missed Q2 2026 earnings and revenue estimates despite higher operating profit from petrochemical spreads, causing shares to fall. Management cited tactical gains amid structural challenges lik
Braskem S.A. reported Q2 2026 earnings with an EPS of $1.62, surpassing analyst estimates. Conversely, revenue totaled $4.16 billion, missing forecasts by approximately $523 million.
Braskem shares fell 5.6% following a disappointing earnings report with a negative net margin of 13.72%. Analysts maintain a 'Strong Sell' consensus as institutional investors adjust holdings.
Braskem SA released a brief Q2 earnings snapshot. The automated summary indicates details may follow, though current information remains minimal.
Braskem reported Q2 2026 operational shifts amid rising oil costs and geopolitical tensions, citing stable Brazilian operations but reduced resin and polymer utilization in the U.S., Europe, and Mexic
Braskem SA reported Q2 2024 earnings, exceeding revenue expectations at $64.11 billion despite missing EPS estimates at -$29.26. The results were presented during an earnings call on August 8, 2024.
Braskem shares fell 4.7% despite beating quarterly earnings and revenue expectations, while analysts maintain a 'Strong Sell' consensus with a $3.40 price target.
Braskem SA reported Q2 2024 earnings, beating revenue expectations at $3.66 billion while missing EPS estimates by $0.63. The financial results were announced on August 8, 2024.
Braskem shares fell over 10% after creditors rejected its financial restructuring proposal following a court protection filing. Debt maturities and subsidiary issues have reignited bankruptcy concerns
Braskem SA reports PE/PP as its largest segment contributing 67.10% of revenue, with Brazil accounting for 60.51% of regional sales.
Braskem reported a 76% surge in first-quarter 2026 EBITDA to $192 million, driven by rebounding petrochemical utilization rates globally. Despite negative operating cash flow, the company maintained a
Braskem reported a significant Q1 2026 EPS beat of $0.5059 against forecasts, driving a 3.42% stock rise despite geopolitical feedstock challenges. The company achieved $3.15 billion in revenue and a
Braskem reported a 76% increase in Q1 2026 EBITDA to $192 million, though high leverage and potential Chapter 11 proceedings for subsidiary Idesa pose significant risks.
Braskem SA posted a Q1 profit of $275 million ($0.69 per share) on $2.95 billion revenue, lifting shares to $4.97.
Braskem has named two new next-generation tankers, "Beautiful Future" and "Blooming Future," designed to reduce CO2 emissions while transporting naphtha from the U.S. Gulf Coast to Brazil. This fleet
Rosen Law Firm filed a securities class action against Braskem S.A., alleging misleading statements about the safety and sustainability of its salt mining operations. Investors with losses exceeding $
Braskem S.A. filed an amended Form 6-K detailing its 2026 corporate calendar, including quarterly financial releases and shareholder meetings scheduled between April and November.
Braskem reported mixed Q1 2026 results with improved utilization in Brazil and US segments, while Mexico operations and green bio-products weakened. A TipRanks analyst rates the stock Neutral with a $
ChemBrief